Lynn A. Tetrault sold $3.7M of Rhythm Pharmaceuticals (RYTM)

Executed Jun 22, disclosed Jun 24, 2 days later.

Value, as filed

$3.7M

37,000 sh × $100.32

Executed

Jun 22

the trade date, as filed

Disclosed

Jun 24

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

LT Lynn A. Tetrault Director profile →

Lynn A. Tetrault (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Rhythm Pharmaceuticals, Inc. (RYTM). The largest single filing was $3.7M of RYTM (37,000 sh × $100.32, as filed), executed Jun 22.

The name

RYTM Rhythm Pharmaceuticals, Inc. RYTM · Healthcare · 47 filings in 24 months ticker →

Healthcare · Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United State…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Lynn A. Tetrault in RYTM

RYTMSALE Rhythm Pharmaceuticals, Inc. $1.0M
20,350 sh across 3 lots
Exec Sep 9 2024
Filed Sep 11 2024 · 5:30 PM ET